Limitation of Ribosomal Protein L11 Availability in vivo Affects Translation Termination

2002 ◽  
Vol 319 (2) ◽  
pp. 329-339 ◽  
Author(s):  
Natalya Van Dyke ◽  
Wenbing Xu ◽  
Emanuel J. Murgola
2007 ◽  
Vol 35 (21) ◽  
pp. 7109-7117 ◽  
Author(s):  
Alberto García-Marcos ◽  
Antonio Morreale ◽  
Esther Guarinos ◽  
Elisa Briones ◽  
Miguel Remacha ◽  
...  

2006 ◽  
Vol 281 (7) ◽  
pp. 4548-4556 ◽  
Author(s):  
Lamine Bouakaz ◽  
Elli Bouakaz ◽  
Emanuel J. Murgola ◽  
Måns Ehrenberg ◽  
Suparna Sanyal

2003 ◽  
Vol 23 (23) ◽  
pp. 8902-8912 ◽  
Author(s):  
Yanping Zhang ◽  
Gabrielle White Wolf ◽  
Krishna Bhat ◽  
Aiwen Jin ◽  
Theresa Allio ◽  
...  

ABSTRACT The gene encoding p53 mediates a major tumor suppression pathway that is frequently altered in human cancers. p53 function is kept at a low level during normal cell growth and is activated in response to various cellular stresses. The MDM2 oncoprotein plays a key role in negatively regulating p53 activity by either direct repression of p53 transactivation activity in the nucleus or promotion of p53 degradation in the cytoplasm. DNA damage and oncogenic insults, the two best-characterized p53-dependent checkpoint pathways, both activate p53 through inhibition of MDM2. Here we report that the human homologue of MDM2, HDM2, binds to ribosomal protein L11. L11 binds a central region in HDM2 that is distinct from the ARF binding site. We show that the functional consequence of L11-HDM2 association, like that with ARF, results in the prevention of HDM2-mediated p53 ubiquitination and degradation, subsequently restoring p53-mediated transactivation, accumulating p21 protein levels, and inducing a p53-dependent cell cycle arrest by canceling the inhibitory function of HDM2. Interference with ribosomal biogenesis by a low concentration of actinomycin D is associated with an increased L11-HDM2 interaction and subsequent p53 stabilization. We suggest that L11 functions as a negative regulator of HDM2 and that there might exist in vivo an L11-HDM2-p53 pathway for monitoring ribosomal integrity.


2004 ◽  
Vol 186 (17) ◽  
pp. 5819-5825 ◽  
Author(s):  
Dale M. Cameron ◽  
Steven T. Gregory ◽  
Jill Thompson ◽  
Moo-Jin Suh ◽  
Patrick A. Limbach ◽  
...  

ABSTRACT The ribosomal protein L11 in bacteria is posttranslationally trimethylated at multiple amino acid positions by the L11 methyltransferase PrmA, the product of the prmA gene. The role of L11 methylation in ribosome function or assembly has yet to be determined, although the deletion of Escherichia coli prmA has no apparent phenotype. We have constructed a mutant of the extreme thermophile Thermus thermophilus in which the prmA gene has been disrupted with the htk gene encoding a heat-stable kanamycin adenyltransferase. This mutant shows no growth defects, indicating that T. thermophilus PrmA, like its E. coli homolog, is dispensable. Ribosomes prepared from this mutant contain unmethylated L11, as determined by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), and are effective substrates for in vitro methylation by cloned and purified T. thermophilus PrmA. MALDI-TOF MS also revealed that T. thermophilus L11 contains a total of 12 methyl groups, in contrast to the 9 methyl groups found in E. coli L11. Finally, we found that, as with the E. coli methyltransferase, the ribosomal protein L11 dissociated from ribosomes is a more efficient substrate for in vitro methylation by PrmA than intact 70S ribosomes, suggesting that methylation in vivo occurs on free L11 prior to its incorporation into ribosomes.


2006 ◽  
Vol 281 (34) ◽  
pp. 24304-24313 ◽  
Author(s):  
Mu-Shui Dai ◽  
Dingding Shi ◽  
Yetao Jin ◽  
Xiao-Xin Sun ◽  
Yanping Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document